Crossmark

Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

Crossref DOI link: https://doi.org/10.1186/s40425-019-0714-x

Published Online: 2019-09-05

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abu-Sbeih, Hamzah

Herrera, Lauren Nicholas

Tang, Tenglong

Altan, Mehmet

Chaftari, Anne-Maria P.

Okhuysen, Pablo C.

Jenq, Robert R.

Wang, Yinghong http://orcid.org/0000-0002-5148-6130
License Information

Text and Data Mining valid from 2019-09-05
More Information

Article History

Received: 21 May 2019

Accepted: 21 August 2019

First Online: 5 September 2019

Change Date: 17 December 2019

Change Type: Correction

Change Details: Following publication of the original article [1], the authors have reported that an author’s name has been incorrectly spelled: the correct given name is Anne-Marie (instead of Anne-Maria P) and family name is Chaftari.

Ethics approval and consent to participate

: The ethics approval of this study was granted by the IRB committee at the University of Texas MD Anderson Cancer Center (PA18–0472). The consent was waived for this study.

: This study was granted waiver for consent.

: The authors declare that they have no competing interests.